ALTERED EPIDERMAL GROWTH-FACTOR SIGNAL-TRANSDUCTION IN ACTIVATED HA-RAS-TRANSFORMED HUMAN KERATINOCYTES

被引:22
作者
CHEN, LL
NARAYANAN, R
HIBBS, MS
BENN, PA
CLAWSON, ML
LU, G
RHIM, JS
GREENBERG, B
MENDELSOHN, J
机构
[1] UNIV CONNECTICUT, CTR HLTH, DEPT MED, DIV RHEUMATOL, FARMINGTON, CT 06032 USA
[2] UNIV CONNECTICUT, CTR HLTH, DEPT PEDIAT, FARMINGTON, CT 06032 USA
[3] DEPT VET AFFAIRS MED CTR, NEWINGTON, CT 06111 USA
[4] HOFFMANN LA ROCHE INC, DIV ONCOL, NUTLEY, NJ 07110 USA
[5] MEM SLOAN KETTERING CANC CTR, RECEPTOR BIOL LAB, NEW YORK, NY 10021 USA
[6] NCI, BETHESDA, MD 20892 USA
[7] CORNELL UNIV, MED CTR, COLL MED, NEW YORK, NY 10021 USA
关键词
D O I
10.1006/bbrc.1993.1605
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Epidermal growth factor (EGF) can stimulate proliferation and 92 kDa gelatinase/matrix metalloproteinase (MMP-9) expression. The induction of MMP-9 is not only pathologically significant for invasion and metastasis, but also serves as a semiquantitative measure of EGF signal transduction. In order to examine the role of mutated ras p21 in EGF signal transduction, an activated Ha-ras-transformed human keratinocyte cell line was developed and characterized. Overexpression of the mutated Ha-ras p21 in these cells was demonstrated. Our results showed that EGF induced 92 kDa MMP-9 secretion was doubled in the ras-transformed keratinocytes in comparison to the parent cells. The karyotype, the expression of EGF receptor (EGFR) and transforming growth factor (TGF) alpha at the mRNA level remained unchanged. These results suggest that the presence of high levels of mutated ras p21 may be responsible for the aberrant EGF signal transduction and contributes to transformation. In addition, a reduction of TGF beta expression at mRNA level by 70% was found in the activated Ha-ras-transformed keratinocytes when compared to the parent cells. © 1993 Academic Press, Inc.
引用
收藏
页码:167 / 174
页数:8
相关论文
共 34 条
[1]  
BENN PA, 1986, HUMAN CYTOGENETICS P, P57
[2]  
BOS JL, 1989, CANCER RES, V49, P4682
[3]  
BOS JL, 1987, NATURE, V327, P929
[4]   CALCIUM-REGULATED DIFFERENTIATION OF NORMAL HUMAN EPIDERMAL-KERATINOCYTES IN CHEMICALLY DEFINED CLONAL CULTURE AND SERUM-FREE SERIAL CULTURE [J].
BOYCE, ST ;
HAM, RG .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1983, 81 (01) :S33-S40
[5]   HUMAN TRANSFORMING GROWTH FACTOR-ALPHA - PRECURSOR STRUCTURE AND EXPRESSION IN ESCHERICHIA-COLI [J].
DERYNCK, R ;
ROBERTS, AB ;
WINKLER, ME ;
CHEN, EY ;
GOEDDEL, DV .
CELL, 1984, 38 (01) :287-297
[6]   TRANSFORMING GROWTH FACTOR-ALPHA [J].
DERYNCK, R .
CELL, 1988, 54 (05) :593-595
[7]   CLONING AND SEQUENCING OF A DEOXYRIBONUCLEIC-ACID COPY OF GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE MESSENGER RIBONUCLEIC-ACID ISOLATED FROM CHICKEN MUSCLE [J].
DUGAICZYK, A ;
HARON, JA ;
STONE, EM ;
DENNISON, OE ;
ROTHBLUM, KN ;
SCHWARTZ, RJ .
BIOCHEMISTRY, 1983, 22 (07) :1605-1613
[8]   IDENTIFICATION OF A CHROMOSOME-18Q GENE THAT IS ALTERED IN COLORECTAL CANCERS [J].
FEARON, ER ;
CHO, KR ;
NIGRO, JM ;
KERN, SE ;
SIMONS, JW ;
RUPPERT, JM ;
HAMILTON, SR ;
PREISINGER, AC ;
THOMAS, G ;
KINZLER, KW ;
VOGELSTEIN, B .
SCIENCE, 1990, 247 (4938) :49-56
[9]  
FROLIK CA, 1984, J BIOL CHEM, V259, P995
[10]   PREVALENCE OF ABERRANT EXPRESSION OF THE EPIDERMAL GROWTH-FACTOR RECEPTOR IN HUMAN CANCERS [J].
GULLICK, WJ .
BRITISH MEDICAL BULLETIN, 1991, 47 (01) :87-98